Medtronic, Inc. (MDT): Is This Stock in Your Portfolio? If Not, Then Consider Getting Some

Page 1 of 2

The market gives investors a good number of chances to buy stocks when they are beaten down, and one such opportunity presented itself when medical devices maker Medtronic, Inc. (NYSE:MDT) slipped in February this year. There were concerns about the company’s business slowing down, but its fourth-quarter results, which were released in May, put such doubts to rest.

Medtronic’s huge size and diversification have helped the company overcome challenges, so it is not surprising that shares have continued their steady appreciation so far this year, rising almost 30%. And once you consider the company’s prospects, it won’t be surprising if the stock continues to fly higher.

An important turnaround

Medtronic, Inc. (NYSE:MDT)

For starters, Medtronic, Inc. (NYSE:MDT)’s implantable cardioverter defibrillators (ICD) and pacemakers, which were the primary reason behind the bearishness of analysts on the stock, are back on the growth path. Sales of defibrillators grew 2% in the previous quarter while pacemaker revenue improved 5% (both excluding currency effects) from the year-ago period.

These improvements are really significant, as both these products were struggling but now seem to be growing again as Medtronic, Inc. (NYSE:MDT) gained market share, and more importantly, helped revenue from its Cardiac Rhythm Disease Management (CRDM) business grow 4% (excluding currency effects). This should have come as welcome relief to Medtronic investors as CRDM has struggled of late.

This market share gain in the CRDM doesn’t come as a surprise as Medtronic, Inc. (NYSE:MDT) was well-positioned to gain from the deficiencies in the ICD offering of its competitor, St. Jude Medical, Inc. (NYSE:STJ). St. Jude’s ICD, the Riata, has faced difficult times and was the subject of a recall in late 2011. The leads inside the defibrillator could break out of the insulation from the inside, according to The Wall Street Journal, and this should have played a part in Medtronic’s share gain.

Now, Medtronic, Inc. (NYSE:MDT) is looking to maintain its new-found momentum in ICD by launching new and improved devices, such as the Evera ICD. Evera would be of smaller size, and the company has made an effort to increase patient comfort through it. Such moves should help Medtronic keep its market share intact in this segment.

Growth ahead

Next, Medtronic has been aggressively focusing on emerging markets to drive international growth. The company’s international revenue has grown consistently in a range of 6%-8% for almost three years, and emerging markets have been the primary drivers of this growth. Going forward, the company is confident of keeping its momentum intact as it increases its presence and builds awareness.

Moreover, Medtronic, Inc. (NYSE:MDT) has been making some notable moves of late as far as new products are concerned. Its advanced insulin pump, which can automate delivery of insulin for Type 1 diabetics through a “threshold suspend” feature is being touted as a breakthrough technology. The company has filed for FDA approval of the device and if approved, it would be a big boost for it.

Also, Medtronic recently received the CE mark for its CoreValve device in Europe, which should improve its standing in the competitive heart valve market in Europe. In addition, its Pacific Plus PTA catheter also received the go-ahead from the FDA along with the European CE mark. These product moves should complement Medtronic’s global presence and help its revenue grow going forward.

Risks to consider

However, being a medical devices manufacturer, Medtronic, Inc. (NYSE:MDT) isn’t immune to the perils of the industry. For instance, the company’s spine business has been a mixed performer and a recent revelation that its Infuse bone graft product, which accelerates bone growth after spinal surgery, doesn’t enjoy an advantage over traditional bone graft procedures led to a dip in share price and might lead to a decline in sales of the product.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Burger Kings: The 10 Most Expensive Burgers in the World

The 10 Most Ethnically Diverse Countries in the World

The 10 Most Exclusive Credit Cards in the World

The 10 Most Expensive Cruise Ships in the World

The 10 Fastest Supercomputers in the World

The 10 Best Countries for Doing Business 2015

6 Most Expensive Fruits In The World

10 Worst Airlines in the World

The 10 Biggest Tax Havens in the World to Stash Your Money

The 15 Most Murderous Countries in the World

10 Largest Colleges in the World: Bigger Isn’t Always Better

Comedians in Cars Getting Coffee: The 6 Comedians Seinfeld Needs to Interview

Easy Money: The 10 Most Successful Investors in the World Today

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!